| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T120 |
0-118 |
Sentence |
denotes |
Neurological symptoms have been sporadically reported in COVID-19 patients but have not yet been well studied [48,49]. |
| T121 |
119-243 |
Sentence |
denotes |
The current body of evidence suggests that the SARS-CoV-2 can affect the nervous system in previously unsuspected ways [50]. |
| T122 |
244-337 |
Sentence |
denotes |
The neuroinvasive capabilities of the SARS-CoV-2 doubtless exist but remain to be elucidated. |
| T123 |
338-465 |
Sentence |
denotes |
Observed neurological symptoms of COVID-19 include febrile seizures, convulsions, mental status changes, and encephalitis [51]. |
| T124 |
466-623 |
Sentence |
denotes |
Among the most commonly reported possibly neurological symptoms of COVID-19 are nonspecific symptoms, such as headache, myalgia, dizziness, and fatigue [21]. |
| T125 |
624-777 |
Sentence |
denotes |
In a study at a single center in China (n = 214), 36.4% (n = 78) of hospitalized COVID-19 patients had what were identified as neurological symptoms[52]. |
| T126 |
778-952 |
Sentence |
denotes |
In a multicenter retrospective study from Europe of 417 patients who recovered from mild to moderate COVID-19, 86% reported olfactory dysfunction and 88% problems with taste. |
| T127 |
953-1052 |
Sentence |
denotes |
In fact, in 12% of patients, the loss of the sense of smell was the first symptom of COVID-19 [53]. |
| T128 |
1053-1345 |
Sentence |
denotes |
The loss of smell has emerged as being more prevalent among patients infected with COVID-19 than patients infected with other viruses or with other types of respiratory conditions [54] and has been recommended as a symptom that may help guide earlier diagnosis and treatment of COVID-19 [55]. |
| T129 |
1346-1474 |
Sentence |
denotes |
In a meta-analysis (n = 1,627 patients, 10 studies), a loss of the sense of smell was reported in 53% of COVID-19 patients [55]. |
